Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Reduced Antibody Acquisition with Increasing Age following Vaccination with BNT162b2: Results from Two Longitudinal Cohort Studies in The Netherlands
Lotus L. van den Hoogen, Mardi C. Boer, Abigail Postema, et al.
Vaccines (2022) Vol. 10, Iss. 9, pp. 1480-1480
Open Access | Times Cited: 18

Showing 18 citing articles:

High SARS-CoV-2 antibody levels after three consecutive BNT162b2 booster vaccine doses in nursing home residents
Marloes I. Hofstee, Joanna Kaczorowska, Abigail Postema, et al.
Immunity & Ageing (2025) Vol. 22, Iss. 1
Open Access
Multiple vaccine comparison in the same adults reveals vaccine-specific and age-related humoral response patterns: an open phase IV trial
Marieke van der Heiden, Sudarshan A. Shetty, Elske Bijvank, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 4
Protective mucosal SARS-CoV-2 antibodies in the majority of the general population in the Netherlands
Marije K. Verheul, Joanna Kaczorowska, Marloes I. Hofstee, et al.
Mucosal Immunology (2024) Vol. 17, Iss. 4, pp. 554-564
Closed Access | Times Cited: 3
COVID-19 vaccination-induced antibody responses and waning by age and comorbidity status in a large population-based prospective cohort study
Christina E. Hoeve, Anne J. Huiberts, Brechje de Gier, et al.
Vaccine (2024) Vol. 42, Iss. 25, pp. 126121-126121
Open Access | Times Cited: 3
Repeated COVID-19 mRNA vaccination results in IgG4 class switching and decreased NK cell activation by S1-specific antibodies in older adults
Anne T. Gelderloos, Marije K. Verheul, Irene Middelhof, et al.
Immunity & Ageing (2024) Vol. 21, Iss. 1
Open Access | Times Cited: 2
Booster Immunization Improves Memory B Cell Responses in Older Adults Unresponsive to Primary SARS-CoV-2 Immunization
Marije K. Verheul, Kim H. Nijhof, Mary‐lène de Zeeuw‐Brouwer, et al.
Vaccines (2023) Vol. 11, Iss. 7, pp. 1196-1196
Open Access | Times Cited: 7
Potential determinants of antibody responses after vaccination against SARS-CoV-2 in older persons: the Doetinchem Cohort Study
Yunus Kuijpers, H. Susan J. Picavet, Lia de Rond, et al.
Immunity & Ageing (2023) Vol. 20, Iss. 1
Open Access | Times Cited: 7
Multiple vaccine comparison in the same adults from the VITAL study reveals vaccine-specific and age-related humoral response patterns
Marieke van der Heiden, Sudarshan A. Shetty, Elske Bijvank, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
Humoral SARS–CoV‐2 Vaccine Responses in Patients With Giant Cell Arteritis and Polymyalgia Rheumatica: Decay After Primary Vaccination and Effects of the Booster
Yannick van Sleen, Kornelis S. M. van der Geest, Anne‐Marie Buisman, et al.
Arthritis Care & Research (2023) Vol. 76, Iss. 1, pp. 105-110
Open Access | Times Cited: 4
Ferric carboxymaltose and SARS-CoV-2 vaccination-induced immunogenicity in kidney transplant recipients with iron deficiency: The COVAC-EFFECT randomized controlled trial
Joanna Sophia J. Vinke, Dania Altulea, Michele F. Eisenga, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 6
Contribution of SARS-CoV-2 infection preceding COVID-19 mRNA vaccination to generation of cellular and humoral immune responses in children
Marije K. Verheul, Martijn Vos, Lia de Rond, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 2
Distinct T cell responsiveness to different COVID-19 vaccines and cross-reactivity to SARS-CoV-2 variants with age and CMV status
Jolanda Brummelman, Sara Suarez Hernandez, Lia de Rond, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access
Health Characteristics Associated With Persistence of SARS-CoV-2 Antibody Responses After Repeated Vaccinations in Older Persons Over Time: The Doetinchem Cohort Study
Yunus Kuijpers, Joanna Kaczorowska, H. Susan J. Picavet, et al.
Research Square (Research Square) (2024)
Closed Access
Health characteristics associated with persistence of SARS-CoV-2 antibody responses after repeated vaccinations in older persons over time: the Doetinchem cohort study
Yunus Kuijpers, Joanna Kaczorowska, H. Susan J. Picavet, et al.
Immunity & Ageing (2024) Vol. 21, Iss. 1
Open Access
Innate immune response after BNT162b2 COVID-19 vaccination associates with reactogenicity
Catharina E van Ewijk, S. Hernandez, Ronald Jacobi, et al.
Vaccine X (2024) Vol. 22, pp. 100593-100593
Open Access
COVID-19 vaccination-induced antibody responses and waning by age and comorbidity status in a large population-based prospective cohort study
CE Hoeve, A. A. M. Huiberts, Brechje de Gier, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 1
Determinants of antibody responses after vaccination against SARS-CoV-2 in older persons. The Doetinchem Cohort Study
Yunus Kuijpers, H. Susan J. Picavet, Lia de Rond, et al.
Research Square (Research Square) (2023)
Open Access
VACCINATION EFFECTIVENESS IN THE POPULATION OF THE ELDERLY PEOPLE AND THE AGING OF THE IMMUNE SYSTEM
Patrycja Zuziak, Krzysztof Przeorski, Marcin Maciej Dereziński, et al.
Postępy Biologii Komórki (2022) Vol. 49, Iss. 3, pp. 193-206
Open Access
Page 1

Scroll to top